The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
51
consume 1 bottle per day for 8 weeks
consume 1 bottle per day for 8 weeks
Bo Han Wu
Pingtung City, Taiwan
The change of blood lipid (Triglyceride, total cholestrol, HDL-C, LDL-C)
Venous blood is sampled to measure concentrations of blood lipid (Triglyceride, total cholestrol, HDL-C, LDL-C)
Time frame: Days 1, 28, and 56
The change of ALT and AST
Venous blood is sampled to measure concentrations of ALT and AST
Time frame: Days 1, 28, and 56
The change of MDA
Venous blood is sampled to measure concentrations of MDA
Time frame: Days 1, 28, and 56
The change of blood antioxidants(f-Thiols, t-GSH, GST-RBC, SOD, Total Anit-oxidative Capicity)
Venous blood is sampled to measure concentrations of blood antioxidants(f-Thiols, t-GSH, GST-RBC, SOD, Total Anit-oxidative Capicity)
Time frame: Days 1, 28, and 56
The change of anti-aging gene expression
Venous blood is sampled to measure expression of anti-aging gene
Time frame: Days 1, 28, and 56
The change of cardiovascular endurance
Step test is designed to assess cardiovascular endurance
Time frame: Days 1, 28, and 56
The change of continuous attention test
Continuous attention test is designed to assess cognitive performance
Time frame: Days 1, 28, and 56
The change of fatigue condition
BFI-Taiwan Form is collected to assess fatigue condition
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Days 1, 28, and 56